Sym-013
- Generic Name
- Sym-013
Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2020-08-28
- Lead Sponsor
- Symphogen A/S
- Target Recruit Count
- 32
- Registration Number
- NCT02906670
- Locations
- 🇺🇸
NEXT Oncology, San Antonio, Texas, United States
🇺🇸South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath